Summary:
Click image to enlargeWe are reaching out about an exciting clinical trial opportunity for the Alzheimer’s disease community. Athira Pharma is running a phase 2/3 trial to evaluate the safety and effectiveness of a potential new treatment.
In order to qualify, you must be:
- Diagnosed with Alzheimer’s disease
- 55 to 85 years of age
- Living in the US
- Able to participate in 8 study visits over 8 months
Qualified Participants May Receive:
Study-related costs, including those associated with travel to the study clinic, will be reimbursed.